Reviews on Clinical Pharmacology and Drug Therapy

SCImago Journal & Country Rank
SciteSore by SCOPUS

Quarterly peer-review medical journal published since 2002.

 

Editor-in-Chief

  • Petr D. Shabanov, MD, Dr. Science (Medicine), professor, Head of Pharmacology Department of S.M. Kirov Military Medical Academy.

 

Publisher and founder

 

About

The journal is published with the assistance of "The St. Petersburg scientific organization of pharmacologists" and "The St. Petersburg scientific organization of physiologists, biochemists, pharmacologists of I.M. Sechenov".

The journal publishes original papers reporting fundamental, medical experimental and clinical research, literature reviews, lectures, case reports, and information on all relevant issues of clinical pharmacology, drug therapy and related subjects.

Topics focused on key issues in basic and clinical pharmacology.

The journal is aimed at researchers, physicians, educators of medical academic institutions, scientists, pharmacologists, druggists  and all specialists in related fields of medicine including residents, research fellows, and medical students.

Our mission:

  1. Integrate Russian scientific efforts and vast experience  in development and use of medicines of various groups with international science and create international space for discussion and opinion sharing scientists in the field of clinical pharmacology and drug therapy.
  2. Provide physicians with actual and qualitative scientific information on the most modern and effective medicines.

 

Indexation

  • SCOPUS
  • Russian Science Citation Index
  • Google Scholar
  • Ulrich's Periodicals directory
  • Dimensions
  • Crossref

Announcements More Announcements...

 

'Reviews on Clinical Pharmacology and Drug Therapy' journal accepted for indexing in SCOPUS

Posted: 20.07.2023

 

The 'Reviews on Clinical Pharmacology and Drug Therapy' journal has been successfully evaluated and accepted for indexing in the SCOPUS database.

The Scopus Content Selection & Advisory Board (CSAB) has reviewed the journal and approved it for coverage. The message from CSAB was received on 11.07.2023.

Journal evaluation tracking URL: https://suggestor.step.scopus.com/progressTracker/?trackingID=0544394189A9AFC1 

All articles published in the journal from 2023 are subject for indexation.


 

Current Issue

Open Access Open Access  Restricted Access Access granted  Restricted Access Subscription or Fee Access

Vol 22, No 2 (2024)

Cover Page

Full Issue

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Reviews

Modern view on the effectiveness and safety of non-steroidal anti-inflammatory drugs
Shamal L.L., Shelemekh O.V., Murashko R.A., Glechyan T.R., Galenko-Yaroshevskii P.A.
Abstract

Issues of the effectiveness and safety of drugs remain relevant and controversial. The benefits and risks of drug therapy are two facets of one whole, called pharmacotherapy, which can have undesirable side and even negatively outweigh the benefits. The effectiveness and safety of drugs must be studied comprehensively because new effects of drugs may be discovered and new mechanisms for unregistered indications may be revealed. Moreover, a deep understanding of adverse drug reactions will allow for the accurate prescription of drugs and proper medical supervision of therapy. Nonsteroidal anti-inflammatory drugs are over-the-counter drugs perceived by patients as safe and do not require a doctor’s prescription, which can cause dangerous drug reactions, particularly when used uncontrollably. The review presents literature data from studies on the effectiveness of nonsteroidal anti-inflammatory drugs and current data on new therapeutic effects of individual drugs, risks of adverse reactions, their mechanisms, and treatment methods.

Reviews on Clinical Pharmacology and Drug Therapy. 2024;22(2):115-130
pages 115-130 views
Targeted delivery of the domestic anticancer drug from the group of aziridine triazines (literature review)
Belyaeva O.A., Kachanov D.A., Stukov A.N., Tochilnikov G.V., Pavlysh A.V., Zmitrichenko Y.G., Alexandrov V.A., Semiglazova T.Y., Belyaev A.M.
Abstract

Currently, the targeted delivery of anticancer drugs can significantly increase the effectiveness of therapy, reduce the side effects of systemic chemotherapy, and improve the quality of patients with cancer. This review aimed to summarize data about the domestic antitumor drug 2,4-bis(1-aziridinyl)-6-(2,2-dimethyl-5-hydroxymethyl-1,3-dioxan-5-yl)amino-1,3,5-thriazine (dioxadet), its nanoforms, possibilities of its use in the clinic, and main antitumor nanodrugs clinically introduced in recent years. Library databases (eLibrary, PubMed, CyberLeninka, ResearchGate, Springer, Wiley Online Library, and Elsevier) were searched for relevant information. The literature review summarizes data on the preclinical trials of dioxadet and provides information on its nanoforms, such as nanogels, nanodiamonds, silica particles, and copolymers with lactic and caproic acids. New drug nanoforms open up opportunities to reduce drug side effects and systemic toxicity, maintain optimal therapeutic concentrations, increase the drug circulation time in the blood, and control its release. The possibility of using chemopreparation cytotoxic doses is the main advantage of new nanodrugs. To date, approximately 20 antitumor nanodrugs have been introduced in clinical practice, and some nanodrugs are undergoing preclinical trials or are in various phases of clinical trials. Thus, the development of a new effective nanoform, i.e., dioxadet, makes it possible to ensure targeted drug delivery in higher cytotoxic doses to target cells, increase selective action, and reduce cytostatic toxicity to normal cells.

Reviews on Clinical Pharmacology and Drug Therapy. 2024;22(2):131-144
pages 131-144 views

Original articles

Influence of gel matrix on the wound healing activity of adhesive dressings filled with silver nanoparticles and humic acid applied on a rat burn model
Larionov K.S., Poloskov A.I., Yu Z., Arutyunyan D.A., Tovpeko D.V., Minchenko A.A., Perminova I.V., Glushakov R.I.
Abstract

BACKGROUND: Thermal injuries to the skin (burns) are common household and man-made traumatic injuries in humans. In wartime, thermal injuries are additional damaging factors in combined skin lesions caused by the damaging elements of modern weapons.

AIM: This study aimed to evaluate the effectiveness of gels based on silver nanoparticles in combination with humic acid on the healing of thermal skin injuries (burn wounds) in rats.

MATERIALS AND METHODS: In the experiments on 57 white nonlinear male rats weighing 218–260 g, the wound healing effects of gels with 10% humic acid modified with nanosilver on various bases, prepared in a pharmacopoeial manner, on a grade IIIB thermal skin burn model were examined. The gel bases used in three experimental groups were as follows: sodium carboxymethylcellulose (group Ia, n = 12), polyacrylamide (group Ib, n = 12), and polyethylene glycol (group Ic, n = 12). The comparison group (group II, n = 12) received Levomekol ointment, whereas the control group (group III, n = 8) did not receive treatment. A grade III thermal burn was made on the proximal part of the back under general anesthesia using a thermal applicator with a circular-shaped flat working part with a diameter of 20 mm. Seventy-two hours after the burn, the wound was freed from scab by complete excision along the border of the intact skin, a splinting ring was applied, and the study drugs were administered. The dynamics of the changes in the burn wound were assessed on days 10, 14, 17, 21, 24, and 28 using the Universal Desktop Ruler program.

RESULTS: The average times (median) to reach 75% epithelialization of wounds in groups Ia, Ic, and II were 29.4 ± 0.2, 34 (33–34), and 33.3 ± 0.45 days, respectively, whereas in groups Ib and III, the median time to 75% epithelization was not achieved. The 28-day healing index (%/day) values were 8.6, 4.8, 6.5, 6.1, and 4.4 in groups Ia, Ib, Ic, II, and III, respectively. The dynamics of epithelialization of thermal burns were most pronounced in group Ia, where the sodium carboxymethylcellulose acted as a gel base for humic substances modified with nanosilver.

CONCLUSIONS: The results indicated that the gel added with nanosilver-modified humic substances based on sodium carboxymethylcellulose has a wound healing effect on thermal skin injuries, superior to the effect of the reference drug Levomekol in terms of the healing time of burn wounds.

Reviews on Clinical Pharmacology and Drug Therapy. 2024;22(2):145-152
pages 145-152 views
Early stress in maternal deprivation affects the expression of OX1R in the limbic system of the brain and contributes to the development of anxiety-depressive symptoms in rats
Pyurveev S.S., Dedanishvili N.S., Sekste E.A., Lebedev A.A., Bychkov E.R., Shabanov P.D.
Abstract

BACKGROUND: Depressive states are becoming an increasingly common mental disorder and a serious social problem that places a heavy economic burden on society. Increasing data from preclinical and clinical studies indicate that orexins (neuropeptides, also known as hypocretins) and their receptors are involved in the pathogenesis of depression. The orexinergic system regulates disrupted functions in depressive states, such as sleep, reward system, eating behavior, stress response, and monoaminergic regulation. However, the exact role of orexins in behavioral and neurophysiological disorders in depression is still unclear.

AIM: This study aimed to examine the effect of early postnatal stress on the expression of OX1R orexin in the limbic system and the development of anxiety-depressive symptoms in rats.

MATERIALS AND METHODS: Maternal deprivation was used as a model of early postnatal stress (postpartum days 2–12). The animals were divided into the control (n = 20) and maternal deprivation (n = 20) groups. On day 90 of life, the influence of early postnatal stress on the development of anxiety-depressive symptoms in adult rats was analyzed using a package of behavioral tests, namely, raised cruciform maze, forced swimming Porsolt test, and two-bottle test. After the experiments, the animals were killed by decapitation, the brain was extracted and placed in the cold, and brain structures (hypothalamus and amygdala) were isolated, immediately frozen in liquid nitrogen, and stored at a temperature of −80°C for polymerase chain reaction analysis.

RESULTS: In the “raised cruciform maze,” the maternal deprivation group spent less time in the open arms of the maze, and the time spent in the closed sleeves increased relative to the control, which can be assessed as an increase in anxiety levels. In the Porsolt test, the maternal deprivation group had increased immobilization time relative to the control group. In the two-bottle sucrose preference test, the maternal deprivation group demonstrated a decreased preference for sucrose solution, which indicates the development of anhedonia. In the hypothalamus, the mRNA expression level of OX1R significantly decreased in the experimental group compared with that in the control group. A twofold decrease in the mRNA expression level of OX1R was also observed in the amygdala of the experimental group compared with that of the control group.

CONCLUSIONS: Early stress caused by maternal deprivation resulted in a decrease in OX1R orexin expression in the hypothalamus and amygdala and contributed to the development of anxiety-depressive symptoms in rats.

Reviews on Clinical Pharmacology and Drug Therapy. 2024;22(2):153-162
pages 153-162 views
Antidepressant effect of new coumarin derivatives
Daliev B.B., Klimenko D.I., Karpova I.V., Myznikov L.V., Bychkov E.R., Lebedev A.A., Shabanov P.D.
Abstract

BACKGROUND: The incidence of bipolar disorder is increasing worldwide. The search for new compounds with antidepressant activity and milder adverse drug reactions is an urgent task of modern psychopharmacology.

AIM: This study aimed to analyze the effect of new neuroactive coumarin derivatives on the level of depressive behavior and monoamine metabolism in the brain structures of rats.

MATERIALS AND METHODS: The antidepressant effects of LVM-091, LVM-099, LVM-S144, and IEM-2886 were evaluated in rats subjected to the Porsolt forced swimming test and the metabolism of monoamines in brain structures (LVM-099) using high-performance liquid chromatography.

RESULTS: LVM-091, LVM-099, LVM-S144, and IEM-2886, synthesized from coumarin, decreased the immobilization time of the experimental rats in the Porsolt forced swimming test, indicating the antidepressant effect of these substances. The administration of LVM-099 at a dose of 10 mg/kg increased the level of homovanillic acid and the homovanillic acid-to-dopamine ratio in the nucleus accumbens. LVM-099 also increased 5-hydroxyindoleacetic acid levels and the 5-hydroxyindoleacetic acid-to-serotonin ratio in the nucleus accumbens. In the amygdala, the levels of norepinephrine, dopamine, serotonin, and their metabolites did not change after LVM-099 administration.

CONCLUSIONS: New coumarin derivatives exert antidepressant effects and increase the metabolism of dopamine and serotonin in rat nucleus accumbens, which can be used in the development of new highly effective antidepressants.

Reviews on Clinical Pharmacology and Drug Therapy. 2024;22(2):163-170
pages 163-170 views
Analgesic activity of new ligands of the NMDA receptor complex
Yakovleva E.E., Kamalova M.T., Brusina M.A., Bychkov E.R., Piotrovskiy L.B., Shabanov P.D.
Abstract

BACKGROUND: The activation of spinal cord NMDA receptors is a key factor in the pathogenesis of acute and chronic pain. Therefore, the use of existing NMDA antagonists in analgesic schemes and the development of new compounds targeting the NMDA receptor complex are gaining attention. New ligands of the glutamate NMDA receptor complex are derivatives of imidazole-4,5-dicarboxylic acid. The conformational rigidity of the molecules of imidazole-4,5-dicarboxylic acid derivatives allows for increased selectivity of interaction and reduced side effects.

AIM: This study aimed to investigate the analgesic effect of new ligands of the glutamate NMDA receptor complex, which are derivatives of imidazole-4,5-dicarboxylic acid, in rats using the tail-flick test and the formalin test.

MATERIALS AND METHODS: The analgesic activity of the compounds was examined in a model of acute somatic (thermal) pain in the tail-flick test and model of somatic pain induced by algogens in the formalin test. The tested compounds (IEM-303 and IEM-2044) were administered intraperitoneally at doses of 5, 10, 15, and 20 mg/kg. Мetamizole was used as the comparison drug.

RESULTS: The experiments demonstrated a significant dose-dependent analgesic effect of the tested compounds on the experimental models of acute pain at doses of 5–20 mg/kg. The tail-flick latency increased by 1.4–1.7 times in the IEM-2044 and IEM-303 groups compared with the value in the control group.

CONCLUSIONS: The analgesic activity of the tested compounds at 10–20 mg/kg doses was comparable to that of metamizole, indicating the prospect of developing these agents and further searching for effective and safe analgesics in this pharmacological class.

Reviews on Clinical Pharmacology and Drug Therapy. 2024;22(2):171-178
pages 171-178 views
Involvement of Bdnf, Ntrk2 and Pi3k in the mechanism of binge eating after psychogenic stressors in ontogenesis
Lizunov A.V., Lebedev A.A., Pyurveev S.S., Nadbitova N.D., Goltz V.A., Sekste E.A., Bychkov E.R., Lebedev V.A., Evdokimova N.R., Shabanov P.D.
Abstract

BACKGROUND: The study of the neurochemical mechanisms of food addiction provides experimental modeling of some of its clinical manifestations.

AIM: This study aimed to examine the effect of binge eating after maternal deprivation or after rearing in social isolation on the expression of Bdnf, Ntrk2, and Pi3k in the hypothalamus of rats.

MATERIALS AND METHODS: Animals aged 2–12 days were weaned from their mother for 10 days at 180 min, and males aged 90–100 days were used in the experiments. Another group of animals was reared in individual cages from day 21 after birth, and males aged 90–100 days were used in the experiments. To induce binge eating, the animals received a high-carbohydrate feed (chocolate spread) for 1 h every day or every third day within 30 days. Fifteen minutes before feeding, the paste was placed 5 cm within visual contact.

RESULTS: In groups with intermittent exposure to high-calorie food (the animals received pasta every third day), polymerase chain reaction analysis revealed the expression of the Bdnf, Ntrk2, and Pi3k in the hypothalamus. The expression level of Bdnf was higher in the maternal deprivation group than in the control group. The expression levels of Ntrk2 and Pi3k in rats taking a high-carbohydrate feed were higher in animals reared in isolation than in those reared in the community.

CONCLUSIONS: The results present new pathways for the synthesis of peptide drugs associated with the PI3K/AKT/mTOR signaling pathway for the correction of food addiction caused by psychogenic stress in ontogenesis.

Reviews on Clinical Pharmacology and Drug Therapy. 2024;22(2):179-189
pages 179-189 views
Kiss1 kisspeptin of bony fish and mammalian kisspeptin analogs enhance the communicative behavior of Danio rerio induced by social isolation
Goltz V.A., Lebedev A.А., Eresko S.O., Airapetov M.I., Pyurveev S.S., Bychkov E.R., Bayramov A.A., Lebedev V.A., Shabanov P.D.
Abstract

BACKGROUND: Rodents are often used as a social isolation model. This study investigated the effects of social isolation on Danio rerio. These animals form groups and social hierarchies and exhibit complex social interactions similar to rodents. The expression of some brain genes of fish reared in isolation was found to be different from individuals reared in a group.

AIM: This study aimed to investigate the effect of kisspeptins on the social behavior of Danio rerio in social isolation.

MATERIALS AND METHODS: Fish were placed in 200-mL measuring cups for 48 h. After the social isolation period, bony fish kisspeptins and mammalian kisspeptin analogs were administered, and their effects were tested. The animal was placed in 1-L individual tanks for 15 min and then in the tank with a glass partition, behind which are a group of congeners. Fish were allowed to approach or swim away from the partition. Two patterns were used to assess behavior: latency time and number of swims to the partition.

RESULTS: Compared with the control group with fish kept in social isolation, reliable differences were observed: The number of swims to the partition after isolation was 1.3 times higher than that in the control group (p < 0.05). After the administration of bony fish kisspeptins Kiss1 and Kiss2, no significant changes in the number of swims to the partition were observed. Moreover, after the administration of KS6 and KS10, the number of swims to the aquarium partition increased 1.6 times (p < 0.01) and 1.8 times (p < 0.001), respectively. After the administration of the comparison drug oxytocin, the number of swims to the aquarium partition increased 1.6 times (p < 0.01) compared with that in the untreated isolated group. The latency time of swimming to the partition increased 2.4 times in the untreated isolated group compared with the control group (p < 0.001). Latency time decreased 2.3 times in the group administered with oxytocin compared with the untreated isolated group (p < 0.001). In the group administered with Kiss1, the latency time decreased 2 times (p < 0.001) compared with that in the untreated isolated group. The latency time decreased 5 times (p < 0.001) after KS10 administration and 3.4 times (p < 0.001) after KS6 administration compared with that in the untreated isolated group.

CONCLUSIONS: Thus, social isolation in Danio rerio reduces communicative behavior. Analogs of mammalian kisspeptin, such as Kiss1, of bony fish and oxytocin normalize the communicative behavior of fish after a period of social isolation to the level of the control group.

Reviews on Clinical Pharmacology and Drug Therapy. 2024;22(2):191-203
pages 191-203 views

Clinical pharmacology

Modern approach to pharmacotherapy of chronic insomnia in childhood
Tadtaeva Z.G., Galustyan A.N., Krivoshein A.E., Rusanovsky V.V., Akimov A.A., Sardaryan I.S., Kuritsina N.A.
Abstract

Insomnia is a widespread problem in the pediatric population. The prevalence of insomnia in childhood varies from 5% to 50%. The lack of adequate therapy can lead to chronicity, impairment of cognitive and motor functions, and eventually development of cardiovascular and metabolic diseases, diabetes, and gastrointestinal and mental disorders. Thus, timely identification and treatment of childhood insomnia is important. This study aimed to summarize and systematize current information about the modern approach to pharmacotherapy of chronic insomnia in childhood. Modern and foreign randomized controlled trials over the past 10 years were analyzed. Treatment of chronic insomnia includes non-pharmacological and pharmacological approaches. Behavioral strategies are recommended as first-line treatment for childhood insomnia. The availability of different pharmacological drug groups allows for a personalized approach to treatment. However, the use of off-label drugs requires a justified prescription. The lack of large-scale clinical studies on the effectiveness, tolerability, dosing, and safety profile of drugs implies the need for further research to better understand the risks (negative side effects) and benefits of using such drugs for treating sleep disorders in children.

Reviews on Clinical Pharmacology and Drug Therapy. 2024;22(2):205-217
pages 205-217 views


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies